Use of an Anti-Low Density Lipoprotein Receptor Antibody to Quantify the Role of the LDL Receptor in the Removal of Chylomicron Remnants in the Mouse in Vivo.

Journal of Clinical Investigation - United States
doi 10.1172/jci115419
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation


Related search